Spain, Feb. 23 -- Spain based BIOGEN SPAIN S.L.U. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Supply of Tysabri(R) (Natalizumab) for continuation of treatments. The value of the contract is worth 164995200 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....